CHI Advisors’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $5.33M | Buy |
1,270,027
+75,000
| +6% | +$315K | 2.11% | 12 |
|
|
2023
Q2 | $6.66M | Sell |
1,195,027
-147,164
| -11% | -$820K | 2.02% | 11 |
|
|
2023
Q1 | $7.69M | Sell |
1,342,191
-862,685
| -39% | -$4.94M | 2.04% | 10 |
|
|
2022
Q4 | $2.32M | Buy |
2,204,876
+208,599
| +10% | +$219K | 0.62% | 16 |
|
|
2022
Q3 | $5.35M | Sell |
1,996,277
-37,525
| -2% | -$101K | 1.44% | 13 |
|
|
2022
Q2 | $9.7M | Buy |
2,033,802
+1,141,745
| +128% | +$5.45M | 3.71% | 8 |
|
|
2022
Q1 | $3.65M | Hold |
892,057
| – | – | 1.55% | 17 |
|
|
2021
Q4 | $6.08M | Sell |
892,057
-28,207
| -3% | -$192K | 2.02% | 13 |
|
|
2021
Q3 | $10.7M | Sell |
920,264
-7,000
| -0.8% | -$81.1K | 3.11% | 9 |
|
|
2021
Q2 | $15.8M | Hold |
927,264
| – | – | 3.68% | 8 |
|
|
2021
Q1 | $18.4M | Sell |
927,264
-68,132
| -7% | -$1.35M | 3.68% | 10 |
|
|
2020
Q4 | $20.5M | Sell |
995,396
-13,721
| -1% | -$283K | 5.79% | 7 |
|
|
2020
Q3 | $26.5M | Buy |
+1,009,117
| New | +$26.5M | 9.44% | 3 |
|